Human antibodies take center stage, as they pile up in the list of approved biologics in 2009. Cormac Sheridan reports. Last year was a vintage year for the bio-pharmaceutical industry in two ...

Since May of 1999, the FDA has approved several biologic disease-modifying antirheumatic drugs and targeted synthetic DMARDs for JIA. However, over that time, childhood-onset systemic lupus ...